The gut microbiota plays a crucial role in GLP-1 modulation through: Fermentation of fiber into SCFAs Regulation of bile acids, which in turn activate TGR5 receptors on L-cells, another GLP-1 secretory pathway Promotion of Akkermansia muciniphila, a keystone species associated with mucosal health and metabolic balance Baobab functions as a prebiotic symphony conductor , enriching the gut ecosystem to support GLP-1 activity from multiple directions
[2] Holst JJ
Abbreviations ADVANCE: action in diabetes and vascular disease AMI: acute myocardial infarction BID: twice daily bpm: beats per minute CI: confidence interval CVOT: cardiovascular outcome trial ELIXA: Evaluation of LIXisenatide in Acute coronary syndrome FIGHT: Functional Impact of GLP-1 for Heart Failure Treatment GLP-1 RA: glucagon-like peptide-1 receptor agonist HF: heart failure HR: heart rate LAR: long-acting release LEADER: Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results LIVE: Effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes LS: least squares PK: pharmacokinetic QD: once daily QW: once weekly SE: standard error T2DM: type 2 diabetes mellitus References Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR
These models have provided crucial insights into the immunological pathways that drive autoimmune thyroid diseases and have been essential for developing potential immunomodulatory therapies aimed at modulating the autoimmune response in Hashimotos thyroiditis (Qian et al
Topical
